Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment
Status unconfirmed
Conditions studied: Breast Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2), Acquired Lymphedema, Congenital Lymphedema
In brief
The goal of this prospective, observational study is to investigate the clinical, psychosocial, and patient satisfaction outcomes of patients who undergo perforator flap reconstruction for breast reconstruction and/or vascularized lymph node transfer (VLNTx) for the treatment of lymphedema. The investigators hypothesize that (1) perforator flap breast reconstruction will result in excellent clinical, psychosocial, and patient satisfaction outcomes compared to non-perforator flap breast reconstruction; (2) perforator flap breast reconstruction is associated with less persistent postsurgical pain than other forms of breast reconstruction, even after controlling for major cofactors, such as the extent of auxiliary lymph node dissection and the use of radiation therapy; (3) perforator flap reconstruction for the treatment of Lymphedema (i.e., VLNTx ) will result in the reduction of symptoms and complications of lymphedema.
Key facts
- Study ID
- NCT01273909
- Run by
- The National Institute of Lymphology
- People needed
- 1000
- Starts
- 2010-07-01
- Expected to finish
- 2016-01-01
- Last updated by the study team
- 2014-06-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Undergoing perforator flap surgery for breast reconstruction and/or vascularized lymph node transfer for treatment of lymphedema
You may not qualify if…
- Pregnant
- unable to read
Where it is running
- National Institute of Lymphology — Chicago, Illinois, United States
- The Center for Restorative Breast Surgery — New Orleans, Louisiana, United States
- The DrMarga Practice Group — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.